Status:
COMPLETED
Fractional Photothermolysis for Treating Melasma
Lead Sponsor:
Laserklinik Karlsruhe
Collaborating Sponsors:
Laser and Skin Centre Potsdam, Potsdam, Germany
Conditions:
Melasma
Eligibility:
All Genders
Phase:
NA
Brief Summary
In several observational studies, non-ablative fractional photothermolysis (FP) has been reported to bridge the gap between efficacy and tolerability in the treatment of melasma. While some beneficial...
Eligibility Criteria
Inclusion
- Adults (female/male) with clinical evidence of melasma;
- Fitzpatrick skin phototype I-III;
- Ability and willingness to comply with the requirements of the protocol.
Exclusion
- Pregnancy or nursing;
- Inability to avoid sun exposure for occupational reasons (e.g., gardeners);
- Known history or clinically relevant allergy to components of the sunscreen or topical anaesthetic;
- Use of topical retinoids within 3 months prior to study enrolment;
- Use of topical hydroquinone within 6 months prior to study enrolment;
- Use of topical corticosteroids within 1 month prior to study enrolment;
- Use of topical cosmetic depigmenting agents within 2 weeks prior to study enrolment;
- Laser surgery procedures within the treatment region during the last 12 weeks prior to enrolment;
- Coagulation disorders or anticoagulant treatment;
- Photo-sensitizing medication (e.g., tetracyclines, gold).
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT01245881
Start Date
March 1 2008
End Date
December 1 2009
Last Update
November 23 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Laserklinik Karlsruhe
Karlsruhe, Germany, 76133